Fortitude Family Office, LLC Amneal Pharmaceuticals, Inc. Transaction History
Fortitude Family Office, LLC
- $305 Billion
- Q2 2025
A detailed history of Fortitude Family Office, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 794 shares of AMRX stock, worth $6,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
794
Previous 966
17.81%
Holding current value
$6,542
Previous $8.1 Million
20.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
245Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$130 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.5 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$61.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.25B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...